Renaissance Technologies
AMIX

Renaissance Technologies’s Autonomix Medical AMIX Stock Holding History

Renaissance Technologies’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40
Closed -$16K – 3953
2024
Q2 		$16K Buy
+40
New +$39.6K ﹤0.01% 3401

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's AMIX Position: Q3 2024 in Review

Renaissance Technologies sold out of Autonomix Medical (AMIX) in Q3 2024, closing a stake of 40 shares — an estimated $16K sold.

Renaissance Technologies first reported a position in AMIX in Q2 2024 and held it in 1 quarter. The position peaked at $16K in Q2 2024. 12 funds tracked by Wall St. Rank hold AMIX as of Q3 2024.

  • Renaissance Technologies reported no remaining Autonomix Medical position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 40 Autonomix Medical shares in Q3 2024, an estimated $16K.
  • Renaissance Technologies first reported a position in Autonomix Medical in Q2 2024 and held it in 1 quarter.
  • Renaissance Technologies's Autonomix Medical position peaked at $16K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held Autonomix Medical as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.